Analyst Expectations for Enanta Pharma's Future
Portfolio Pulse from Benzinga Insights
In the last quarter, Enanta Pharma (NASDAQ:ENTA) received 3 bullish, 1 somewhat bullish, and 4 indifferent analyst ratings. Over the past 3 months, 8 analysts have offered 12-month price targets for Enanta Pharma, with an average price target of $31.38, a decrease of 27.7% from the previous average price target of $43.40.
October 23, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Enanta Pharma has received mixed analyst ratings in the last quarter, with the average price target decreasing by 27.7% to $31.38.
The mixed analyst ratings indicate uncertainty about the company's future performance. The significant decrease in the average price target suggests that analysts have lowered their expectations for the stock, which could potentially impact investor sentiment and the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100